[HTML][HTML] Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and …
Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an
increasing amount of resources in the United States health care system. Overall rates of …
increasing amount of resources in the United States health care system. Overall rates of …
SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions
DN Feldman, EJ Armstrong… - … : official journal of …, 2018 - pubmed.ncbi.nlm.nih.gov
SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions SCAI
consensus guidelines for device selection in femoral-popliteal arterial interventions Catheter …
consensus guidelines for device selection in femoral-popliteal arterial interventions Catheter …
Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry
A Schmidt, M Piorkowski, H Görner, S Steiner… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: The authors sought to investigate the efficacy of a drug-coated balloon (DCB) for
treatment of complex femoropopliteal lesions. Background: Superiority of DCBs compared …
treatment of complex femoropopliteal lesions. Background: Superiority of DCBs compared …
Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: the randomized femoral artery in-stent restenosis (FAIR) trial
H Krankenberg, T Tübler, M Ingwersen, M Schlüter… - Circulation, 2015 - Am Heart Assoc
Background—Drug-coated balloon angioplasty (DCBA) was shown to be superior to
standard balloon angioplasty (POBA) in terms of restenosis prevention for de novo …
standard balloon angioplasty (POBA) in terms of restenosis prevention for de novo …
Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for isolated popliteal artery lesions
K Stavroulakis, A Schwindt, G Torsello… - Journal of …, 2017 - journals.sagepub.com
Purpose: To report a single-center study comparing drug-coated balloon (DCB) angioplasty
vs directional atherectomy with antirestenotic therapy (DAART) for isolated lesions of the …
vs directional atherectomy with antirestenotic therapy (DAART) for isolated lesions of the …
Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence
K Bishu, EJ Armstrong - Vascular health and risk management, 2015 - Taylor & Francis
Femoropopliteal lesions account for a significant proportion of endovascular interventions
for peripheral artery disease in patients with disabling claudication or chronic limb ischemia …
for peripheral artery disease in patients with disabling claudication or chronic limb ischemia …
Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK
Objectives To estimate the clinical and economic impact of drug-eluting endovascular
treatment strategies for femoropopliteal artery disease compared with current standard of …
treatment strategies for femoropopliteal artery disease compared with current standard of …
An experimental evaluation of the mechanics of bare and polymer-covered self-expanding wire braided stents
CG McKenna, TJ Vaughan - Journal of the Mechanical Behavior of …, 2020 - Elsevier
Self-expanding wire braided stents have been used in a wide-range of medical implant
applications due to the distinct flexibility offered by the wide-range of tunable design …
applications due to the distinct flexibility offered by the wide-range of tunable design …
Real-world results of supera stent implantation for popliteal artery atherosclerotic lesions: 3-year outcome
EM San Norberto, CM Flota, L Fidalgo-Domingos… - Annals of vascular …, 2020 - Elsevier
Background Reports our experience for the first 50 cases of use of Supera stent for popliteal
atherosclerotic lesions treatment. Methods This prospective single-arm trial enrolled the first …
atherosclerotic lesions treatment. Methods This prospective single-arm trial enrolled the first …
Short-term Results of the RAPID Ra ndomized Trial of the Legflow P aclitaxel-Eluting Balloon With Supera Stenting vs Supera Stenting Alone for the Treatment of I …
SW de Boer, DAF van den Heuvel… - Journal of …, 2017 - journals.sagepub.com
Purpose: To report a randomized trial comparing the Legflow paclitaxel-eluting balloon
(PEB)+ Supera stenting to Supera stenting alone in patients with intermediate to long …
(PEB)+ Supera stenting to Supera stenting alone in patients with intermediate to long …